And there you have it. Catherine Owen-Jones is out to turn ACAD into a Global Neuro Drug Powerhouse.
It’s hard to imagine she could not be casting her greedy eyes over 2591.
2591 is all she needs to be a Global Powerhouse. How does she put together deal that gives her control.
With a $Billion in sales and growing she’s got access to debt funding. She’s got access to Capital Funding. She’s got shares she can swap out. She got $700M in cash.
Watch closely we’ve got a very exciting few months ahead.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.29 |
Change
0.660(3.97%) |
Mkt cap ! $2.178B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $9.078M | 529.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1334 | $17.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.33 | 2245 | 3 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |